Clinical Trials Directory

Trials / Completed

CompletedNCT04634903

Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19

Comparing Two Online Single-Session Interventions for Adolescent Depression: Outcomes of a Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,452 (actual)
Sponsor
Stony Brook University · Academic / Other
Sex
All
Age
13 Years – 16 Years
Healthy volunteers
Not accepted

Summary

Most mental health problems emerge by age 14, often leading to chronic impairments and adverse impacts for individuals, families, and societies. Any action-focused path to reducing the need-to-access gap will require moving beyond the dominant settings, formats, and systems that have constrained intervention delivery to date. In a fully-online trial, youths ages 13-16 will be randomized to 1 of 3 self-administered single-session interventions (SSIs): a behavioral activation SSI, targeting behavioral MD symptoms; an SSI teaching growth mindset, targeting cognitive MD symptoms; or a control SSI. The investigators will test each SSI's relative benefits, versus the control, on depressive symptoms and proximal outcomes such as hopelessness. Results will reveal whether SSIs that were designed to address behavioral versus cognitive symptoms differentially benefit adolescents with elevated depressive symptoms.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSupportive Therapy SSIOnline, 30-minute self-administered program for youth
BEHAVIORALBehavioral Activation SSIOnline, 30-minute self-administered program for youth
BEHAVIORALGrowth Mindset SSIOnline, 30-minute self-administered program for youth

Timeline

Start date
2020-11-19
Primary completion
2021-03-15
Completion
2021-03-15
First posted
2020-11-18
Last updated
2021-05-25
Results posted
2021-05-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04634903. Inclusion in this directory is not an endorsement.